Insulinlike Growth Factors in Human Malignancy

References

• Blundell T L, Humbel RE. Hormone families: pancreatic hormones and homologous growth factors. Nature 1980; 287: 781–787
   PubMed Web of Science ®Google Scholar
• Baxter RC. The somatomedins: Insulin-like growth factors. Adv Clin Chem 1986; 25: 49–115
   PubMed Web of Science ®Google Scholar
• Nissley S P, Rechler MM. Insulin-like growth factors: biosynthesis, receptors, and carrier proteins. Hormonal Proteins Peptides 1986; 12: 127–203
   Google Scholar
• Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with pro-insulin. J Biol Chem 1978; 253: 2769–2776
   PubMed Web of Science ®Google Scholar
• Rinderknecht E, Humbel RE. Primary structure of human insulin-like growth factor II. FEBS Lett 1978; 89: 283–286
   PubMed Web of Science ®Google Scholar
• Mathews L S, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci (USA) 1988; 83: 9343–9347
   Web of Science ®Google Scholar
• Han V KM, Lund P K, Lee DC, et al. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metab 1988; 66: 422–429
   PubMed Web of Science ®Google Scholar
• Clemmons D R, Van Wyk J J, Ridgway EC, et al. Evaluation of acromegaly by radioimmunoassay of Somatomedin-C. N Engl J Med 1979; 301: 1138–1142
   PubMed Web of Science ®Google Scholar
• Eshet R, Laron Z, Pertzelan A, et al. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci 1984; 20: 8–11
   PubMedGoogle Scholar
• Jansen M, Van Schaik F M, Van Tol H, et al. Nucleotide sequence of cDNAs encoding precursors of human insulin-like growth factor II and an IGF-II variant. FEBS Lett 1985; 179: 243–248
   PubMed Web of Science ®Google Scholar
• Hampton B, Burgess W H, Cullen KJ, et al. Isolation and characterization of a variant form of human insulin-like growth factor II. Proc Endocr Soc 1989; A602
   Google Scholar
• Zapf J, Froesch VR. Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological roles. Hormone Res 1986; 24: 121–130
   PubMed Web of Science ®Google Scholar
• Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define hormonal specificity. EMBO J 1986; 5: 2503–2512
   PubMed Web of Science ®Google Scholar
• Massague J, Czech MP. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 1982; 257: 5038–5045
   PubMed Web of Science ®Google Scholar
• Morgan D O, Edman J C, Standring DN, et al. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 1987; 329: 301–307
   PubMed Web of Science ®Google Scholar
• Lobel P, Dahms N M, Breitwmeyer J, et al. Cloning of the bovine 215-kDa cation-independent mannose-six-phosphate receptor. Proc Natl Acad Sci (USA) 1987; 84: 2233–2237
   PubMed Web of Science ®Google Scholar
• Rochefort H, Capony F, Cavalie-Barthez G, et al. Estrogen-regulated proteins and autocrine control of cell growth in breast cancer. Dev Oncol 1986; 43: 57–68
   Google Scholar
• Kovacin K S, Steele-Perkins G, Purchio AF, et al. Interactions of recombinant and platelet transforming growth factor-β1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Comm 1989; 160: 393–403
   PubMed Web of Science ®Google Scholar
• Braulke T, Causin C, Waheed A, et al. Mannose 6-phosphate/insulin-like growth factor II receptor: distinct binding sites for mannose 6-phosphate and insulin-like growth factor II. Biochem Biophys Res Comm 1988; 150: 1287–1293
   PubMed Web of Science ®Google Scholar
• Fradkin J E, Eastman R C, Lesniak MA, et al. Specificity spillover at the hormone receptor-exploring its role in human disease. N Engl J Med 1989; 320: 640–645
   PubMed Web of Science ®Google Scholar
• Ewton D Z, Falen S L, Florini JR. The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: Pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology 1987; 120: 115–123
   PubMed Web of Science ®Google Scholar
• Rosenfeld R G, Conover C A, Hodges D, et al. Heterogeneity of insulin-like growth factor-I affinity for the insulin-like growth factor-II receptor: comparison of natural, synthetic and recombinant DNA-derived insulin-like growth factor I. Biochem Biophys Res Comm 1987; 143: 199–205
   PubMed Web of Science ®Google Scholar
• Froesch E R, Schmid C, Schwander J, et al. Actions of the insulin like growth factors. Ann Rev Physiol 1985; 47: 443–467
   PubMed Web of Science ®Google Scholar
• Rechler M M, Nissley SP. The nature and regulation of the receptors for the insulin-like growth factors. Ann Rev Physiol 1985; 47: 425–442
   PubMed Web of Science ®Google Scholar
• MacDonald R G, Tepper M A, Clairmont KB, et al. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J Biol Chem 1989; 264: 3256–3261
   PubMed Web of Science ®Google Scholar
• Gelato M C, Kiess W, Lee L, et al. The insulin-like growth factor II/mannose-6-phosphate receptor is present in monkey serum. J Clin Endocrinol Metab 1988; 67: 669–675
   PubMed Web of Science ®Google Scholar
• Causin L CL, Waheed A, Braulke T, et al. Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor. Biochem J 1988; 252: 795–799
   PubMed Web of Science ®Google Scholar
• Baxter R C, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989; 1: 49–68
   PubMedGoogle Scholar
• Cohen K L, Nissley SP. The serum half-life of somatomedin activity. Evidence for growth hormone dependence. Acta Endocrinol 1976; 83: 243–258
   PubMedGoogle Scholar
• Lewitt M S, Baxter RC. Regulation of growth hormone independent insulin like growth factor-binding protein (BP-28) in cultured human fetal explants. J Clin Endocrinol Metab 1989; 69: 246–252
   PubMed Web of Science ®Google Scholar
• De Mellow J SM, Baxter RC. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Comm 1988; 156: 199–204
   PubMed Web of Science ®Google Scholar
• Wood W I, Cachianes G, Henzel WJ, et al. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 1988; 2: 1176–1185
   PubMed Web of Science ®Google Scholar
• Baxter R C, Martin JL. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex. Determination by reconstitution and affinity labeling. Proc Natl Acad Sci (USA) 1989; 86: 6898–6902
   PubMed Web of Science ®Google Scholar
• Lee Y L, Hintz R L, James PM, et al. Insulin-like growth factor (IGF) binding protein cDNA from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 1988; 2: 404–411
   PubMed Web of Science ®Google Scholar
• Brewer M, Stetler G L, Squires CH, et al. Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Comm 1988; 152: 1289–1297
   PubMed Web of Science ®Google Scholar
• Margot J B, Binkert C, Mary J L, Landwehr J, Heinrich G, Schwander J. A low molecular weight insulin-like growth factor binding protein from rat: cDNA cloning and tissue distribution of its messenger RNA. Mol Endocrinol 1989; 7: 1053–1060
   Google Scholar
• Romanus J A, Tseng L Y, Yang Y W, Rechler MM. The 34 kilodalton insulin-like growth factor binding proteins in human cerebrospinal fluid and the a673 rhabdomyosarcoma cell line are human homologues of the rat BRL-3A binding protein. Biochem Biophys Res Comm 1989; 163: 875–881
   PubMed Web of Science ®Google Scholar
• Stracke M L, Kohn E C, Aznavoorian SA, et al. Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem Biophys Res Comm 1988; 153: 1076–1083
   PubMed Web of Science ®Google Scholar
• Riccardi V M, Sujansky E, Smith AC, et al. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978; 61: 604–610
   PubMed Web of Science ®Google Scholar
• Waziri M, Patil S R, Hanson JW, et al. Abnormality of chromosome 11 in patients with features of Beckwith-Wiedeman syndrome. J Pediatr 1983; 102: 873–876
   PubMed Web of Science ®Google Scholar
• Morton C C, Byers M G, Nakai H, et al. Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet Cell Genet 1986; 41: 245–249
   PubMedGoogle Scholar
• Reeve A E, Eccles M R, Wilkens RJ, et al. Expression of insulin-like growth factor II transcripts in Wilms' tumor. Nature 1985; 317: 258–260
   PubMed Web of Science ®Google Scholar
• Scott J, Cowell J, Robertson ME, et al. Insulin-like growth factor II gene expression in Wilms' tumor and embryonic tissues. Nature 1985; 317: 260–262
   PubMed Web of Science ®Google Scholar
• Paik S, Rosen N, Chun W, et al. Expression of IGF-II mRNA in fetal kidney and Wilms' tumor; An in-situ hybridization study. Lab Invest 1989
   PubMed Web of Science ®Google Scholar
• Hirvonen H, Sandberg M, Kalimo H, et al. the n-mycproto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. J Cell Biol 1989; 108: 1093–1104
   PubMed Web of Science ®Google Scholar
• Haselbacher G K, Irminger J-C, Zapf J, et al. Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms' tumors: Expression at the mRNA and protein level. Proc Natl Acad Sci (USA) 1987; 84: 1104–1106
   PubMed Web of Science ®Google Scholar
• Gansler T, Allen K D, Burant CF, et al. Detection of type I insulin-like growth factor receptors in Wilms' tumors. Am J Pathol 1988; 130: 431–435
   PubMed Web of Science ®Google Scholar
• Lund P K, Moats-Staats B M, Hynes MA, et al. Somatomedin-C/insulin-like growth factor I and insulin-like growth factor II mRNAs in rat fetal and adult tissues. J Biol Chem 1986; 261: 14539–14544
   PubMed Web of Science ®Google Scholar
• Rotwein P, Burgess S K, Milbrandt JD, et al. Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci (USA) 1988; 85: 265–269
   PubMed Web of Science ®Google Scholar
• McMorris F A, Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res 1988; 21: 199–109
   PubMed Web of Science ®Google Scholar
• Sandberg A C, Engberg C, Lake M, et al. The expression of insulinlike growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett 1988; 93: 114–119
   PubMed Web of Science ®Google Scholar
• Gammeltoft S, Ballotti Z R, Kowalski A, et al. Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 1988; 48: 1233–1237
   PubMed Web of Science ®Google Scholar
• Yee D, Favoni R E, Lebovic GS, et al. Evidence for autocrine growth regulation of primitive neuroectidermal tumors by insulin-like growth factor I (IGF-I). Proc Am Assoc Cancer Res 1989; 30: A283
   Google Scholar
• El-Badry O M, Romanus J A, Helman LJ, et al. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Cell Biochem 1989; 13B: E322
   Google Scholar
• Dahcer M K, Perlman RL. Insulin and Insulin-like growth factors stimulate deoxyribonucleic acid synthesis in PC12 pheochromocytoma cells. Endocrinology 1988; 122: 2109–2113
   PubMed Web of Science ®Google Scholar
• Nielsen F C, Gammeltoft S. Insulin-like growth factors are mitogens for rat pheochromocytoma PC 12 cells. Biochem Biophys Res Comm 1988; 154: 1018–1023
   PubMed Web of Science ®Google Scholar
• Van Dijk J P, Tanswell A K, Challis J RG. Insulin-like growth factor II and insulin, but not IGF-I are mitogenic for fetal rat adrenal cells in vitro. J Endocrinol 1988; 119: 509–516
   PubMed Web of Science ®Google Scholar
• La Rocca R, Danesi R, Stein C, et al. Insulin-like growth factor II mRNA in human adrenocortical carcinoma. Proc Am LAssoc Cancer Res 1989; 30: A246
   Google Scholar
• Daughaday W H, Emanuele M A, Brooks MH, et al. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988; 319: 1434–1440
   PubMed Web of Science ®Google Scholar
• De Larco J E, Todaro GJ. A human fibrosarcoma cell line producing multiplication stimulation activity related peptides. Nature 1978; 272: 356–358
   PubMed Web of Science ®Google Scholar
• Blatt J, White C, Dienes S, et al. Production of an insulin-like growth factor by osteosarcoma. Biochem Biophys Res Comm 1984; 123: 373–376
   PubMed Web of Science ®Google Scholar
• Helman L J, Israel M A, El-Badry OM. Growth inhibition of rhabdomyosarcoma cells by an antibody to the IGF type I receptor. Proc Am Assoc Cancer Res 1989; 30: A245
   Google Scholar
• Hoopener J WM, Mosselman S, Roholl P JM, et al. Expression of insulin-like growth factor I and II genes in human smoothe muscle tumors. EMBO J 1988; 7: 1379–1385
   PubMed Web of Science ®Google Scholar
• Tricoli J V, Rall L B, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986; 46: 6169–6173
   PubMed Web of Science ®Google Scholar
• Hickman J, McElduff A. Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106–01: An osteoblast-like cell. Endocrinology 1989; 124: 701–706
   PubMed Web of Science ®Google Scholar
• Furlanetto R W, DiCarlo JN. Somatomedin-C receptors and growth effects in human breast cells maintained in long term tissue culture. Cancer Res 1984; 44: 2122–2128
   PubMed Web of Science ®Google Scholar
• Myal Y, Shiu R PC, Bhaumick B, et al. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Red 1984; 44: 5486–5490
   PubMed Web of Science ®Google Scholar
• Yee D, Cullen K J, Paik S, et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Red 1988; 48: 6691–6696
   PubMed Web of Science ®Google Scholar
• Karey K P, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17B estradiol. Cancer Res 1988; 48: 4083–4092
   PubMed Web of Science ®Google Scholar
• Zugmaier G, Knabbe C, Beschouer B, et al. Estradiol is synergistic with IGF1 or EGF to stimulate anchorage independent growth of estrogen receptor positive human breast cancer cells in serum supplemented but not in serum free agar. J Cell Biochem 1989; S13B: E450
   Google Scholar
• Huff K K, Kaufman D, Gabbay KH, et al. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 1986; 46: 4613–4619
   PubMed Web of Science ®Google Scholar
• Minuto F, Del Monte P, Barreca A, et al. Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. Mol Cell Endocrinol 1987; 54: 179–184
   PubMed Web of Science ®Google Scholar
• Ahmed S T, Manni A, Gray G, et al. Hormonal regulation and characterization of radioimmunoassayable insulin-like growth factor I activity secreted by human breast cancer cells. Proc Am Assoc Cancer Res 1989; 30: A1162
   Google Scholar
• Yee D, Paik S, Lebovic GS, et al. Analysis of IGF-I gene expression in malignancy, evidence for a paracrine role in human breast cancer. Mol Endocrinol 1989; 3: 509–517
   PubMed Web of Science ®Google Scholar
• Cullen K J, Lippman ME. Estrogen regulation of protein synthesis and cell growth in human breast cancer. Vitamins and Hormones, GD. Aurbach. Academic Press, New York 1989; vol.45
   Google Scholar
• Brünner N, Cullen K J, Yee D, et al. Differential regulation by estradiol (E2) of IGF-I and IGF-II mRNA expression during E2 induced growth inhibition of the T61 human breast cancer xenograft. Proc Endocr Soc 1989; A288
   Google Scholar
• Furlanetto R W, DiCarlo JN. Somatomedin-C receptors and growth effects in human breast cells maintained in long term tissue culture. Cancer Res 1984; 44: 2122–2128
   PubMed Web of Science ®Google Scholar
• De Leon D D, Bakker B, Wilson DM, et al. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Comm 1988; 152: 398–405
   PubMed Web of Science ®Google Scholar
• Pollack M N, Perdue J F, Margolese RG, et al. Presence of somatomedin receptors on human breast and colon carcinomas. Cancer Lett 1987; 38: 223–230
   PubMed Web of Science ®Google Scholar
• Peyrat J-P, Bonneterre J, Beuscart J, et al. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 1988; 48: 6429–6433
   PubMed Web of Science ®Google Scholar
• Peyrat J P, Bonneterre J, Laurent JC, et al. Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. Eur J Cancer Clin Oncol 1988; 24: 1425–1431
   PubMedGoogle Scholar
• Cullen K J, Yee D, Sly WS, et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990; 50: 48–53
   PubMed Web of Science ®Google Scholar
• Rohlid Q T, Adams B, Kull FC, et al. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Comm 1987; 149: 276–281
   PubMed Web of Science ®Google Scholar
• Arteaga C L, Kitten L, Coronado E, et al. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989; 84: 1418–1423
   PubMed Web of Science ®Google Scholar
• De Leon D D, Wilson D M, Bakker B, et al. Characterization of insulin-like growth factor (IGF) binding proteins from human breast cancer cells. Mol Endocrinol 1989; 3: 567–574
   PubMed Web of Science ®Google Scholar
• Yee D, Favoni Lupu R E, et al. The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochem Biophys Res Comm 1989; 158: 38–44
   PubMed Web of Science ®Google Scholar
• Favoni R E, Cubbage M, Powell DR, et al. Multiple insulin-like growth factor binding proteins are produced by human breast cancer cells. The Proceedings 12th Annual San Antonio Breast Cancer Symposium 1989, in press
   Google Scholar
• Coletti R B, Roberts J D, Devlin JT, et al. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 1989; 49: 1882–1884
   PubMed Web of Science ®Google Scholar
• Tricoli J V, Rall L B, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986; 46: 6169–6173
   PubMed Web of Science ®Google Scholar
• Koenuma M, Yamori T, Tsurouo T. Insulin and Insulin-like growth factor I stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 1989; 80: 51–58
   PubMedGoogle Scholar
• Wu J C, Daughaday W H, Lee SD, et al. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med 1988; 112: 589–594
   PubMedGoogle Scholar
• Ueno T, Takahashi K, Matsuguchi T, et al. Transcriptional deviation of the rat insulin-like growth factor II gene initiated at three alternative leader-exons between neonatal tissues and ascites hepatomas. Biochem Biophys Acta 1988; 950: 411–419
   PubMed Web of Science ®Google Scholar
• Su T, Liu W, Han S, et al. Transcripts of the insulin-like growth factors I and II in human hepatoma. Cancer Res 1989; 49: 1774–1777
   Google Scholar
• Moses A C, Freinkel A J, Knowles BB, et al. Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein. J Clin Endocrinol Metab 1983; 56: 1003–1008
   PubMed Web of Science ®Google Scholar
• Lee Y L, Hintz R L, James PM, et al. Insulin-like growth factor binding protein cDNA from human HepG2 hepatoma cells: Predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 1988; 2: 404–411
   PubMed Web of Science ®Google Scholar
• Heaton J H, Krett N L, Gelehrter TD. Regulation of insulin and insulin-like growth factor responsiveness by IGFs in rad hepatoma cells. Endocrinology 1986; 118: 2555–2560
   PubMed Web of Science ®Google Scholar
• Caro J F, Poulos J, Ittoop O, et al. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma and normal, regenerating and fetal rat liver. J Clin Invest 1988; 81: 976–981
   PubMed Web of Science ®Google Scholar
• Scott C D, Taylor J E, Baxter RC. Differential regulation of insulin-like growth factor II receptors in rat hepatocytes and hepatoma cells. Biochem Biophys Res Comm 1988; 151: 815–821
   PubMed Web of Science ®Google Scholar
• Minuto F, Del Monte P, Barreca A, et al. Evidence for an increased somatomedin-C/insulin-like growth factor content in primaty human lung tumors. Cancer Res 1986; 46: 985–988
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Mulshine J, Kasprzyk PG, et al. Insulin-like growth factor I can mediate autocrine proliferation of small cell lung cancer cell lines in vitro. J Clin Invest 1988; 82: 354–359
   PubMed Web of Science ®Google Scholar